The future of microfluidic point-of-care diagnostic devices
LC–MS/MS in clinical laboratories
New center to provide accurate and real-time disease information for patients
Bay Bioanalytical Laboratory merges with Pacific BioLabs
Next-generation sequencing added to Caris Life Science’s molecular profiling arsenal
Algeta and Ablynx collaborate to discover and develop targeted cancer therapies
Merck and Regenstrief enter evidence-based healthcare partnership
Electrochemical bioassay for the detection of TNF-α using magnetic beads and disposable screen-printed array of electrodes
Disposable pipette extraction for the simultaneous determination of biperiden and three antipsychotic drugs in human urine by GC–nitrogen phosphorus detection
Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds
Investigation of metabolite alteration in dimethylnitrosamine-induced liver fibrosis by GC–MS
Iodine-129 microdosing for protein and peptide drug development: erythropoietin as a case study
Development of a fast method for direct analysis of intact synthetic insulins in human plasma: the large peptide challenge
Fit-for-purpose bioanalytical cross-validation for LC–MS/MS assays in clinical studies
A systematic approach for developing a robust LC–MS/MS method for bioanalysis
Acknowledgements